Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|7|898-903

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.7, 2010-03, pp. : 898-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Relationship between Adipokines, Metabolic Parameters and Insulin Resistance in Patients with Metabolic Syndrome and Type 2 Diabetes

By Lee JM   Kim SR   Yoo SJ   Hong OK   Son HS   Chang SA  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1803-1812

Field House Publishing

Access to resources Recommend Favorite

Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 3, 2015-01 ,pp. : 223-228

Bentham Science Publishers

Access to resources Recommend Favorite

Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies

By Chan Dick C   Watts Gerald F  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 13-30

Informa Healthcare

Access to resources Recommend Favorite

Fine Tuning of PPAR Ligands for Type 2 Diabetes and Metabolic Syndrome

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-01 ,pp. : 563-573

Bentham Science Publishers

Access to resources Recommend Favorite

Ezetimibe improves lipid profiles in diabetes and metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite